CLDI
Price
$0.79
Change
-$0.06 (-7.06%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
20.48M
VBIZF
Price
$0.22
Change
+$0.05 (+29.41%)
Updated
Mar 6 closing price
Capitalization
372.37M
Ad is loading...

CLDI vs VBIZF

Header iconCLDI vs VBIZF Comparison
Open Charts CLDI vs VBIZFBanner chart's image
Calidi Biotherapeutics
Price$0.79
Change-$0.06 (-7.06%)
Volume$11K
Capitalization20.48M
Viva Biotech Holdings
Price$0.22
Change+$0.05 (+29.41%)
Volume$10K
Capitalization372.37M
CLDI vs VBIZF Comparison Chart
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. VBIZF commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and VBIZF is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CLDI: $0.81 vs. VBIZF: $0.17)
Brand notoriety: CLDI and VBIZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 42% vs. VBIZF: 3%
Market capitalization -- CLDI: $20.48M vs. VBIZF: $372.37M
CLDI [@Biotechnology] is valued at $20.48M. VBIZF’s [@Biotechnology] market capitalization is $372.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 1 FA rating(s) are green whileVBIZF’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 1 green, 4 red.
  • VBIZF’s FA Score: 1 green, 4 red.
According to our system of comparison, VBIZF is a better buy in the long-term than CLDI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 3 TA indicator(s) are bullish.

  • CLDI’s TA Score: 3 bullish, 7 bearish.

Price Growth

CLDI (@Biotechnology) experienced а -4.32% price change this week, while VBIZF (@Biotechnology) price change was +32.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

CLDI is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VBIZF($372M) has a higher market cap than CLDI($20.5M). VBIZF YTD gains are higher at: 141.326 vs. CLDI (-29.174).
CLDIVBIZFCLDI / VBIZF
Capitalization20.5M372M6%
EBITDA-23.8MN/A-
Gain YTD-29.174141.326-21%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash1.9MN/A-
Total Debt9.02MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CLDI
RSI
ODDS (%)
Bearish Trend 7 days ago
17%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
47%
Momentum
ODDS (%)
Bearish Trend 7 days ago
60%
MACD
ODDS (%)
Bearish Trend 7 days ago
32%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
30%
Advances
ODDS (%)
Bullish Trend about 1 month ago
49%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
84%
Aroon
ODDS (%)
Bearish Trend 7 days ago
89%
View a ticker or compare two or three
Ad is loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

VBIZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VBIZF has been loosely correlated with CLDI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if VBIZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VBIZF
1D Price
Change %
VBIZF100%
N/A
CLDI - VBIZF
34%
Loosely correlated
+10.08%
SRBCF - VBIZF
12%
Poorly correlated
N/A
SPHRY - VBIZF
11%
Poorly correlated
N/A
WXXWY - VBIZF
3%
Poorly correlated
+3.44%
UCBJF - VBIZF
3%
Poorly correlated
+0.01%
More